» Articles » PMID: 18022241

Differences in Structure, Physiological Stability, Electrochemistry, Cytotoxicity, DNA and Protein Binding Properties Between Two Ru(III) Complexes

Overview
Journal J Inorg Biochem
Specialty Biochemistry
Date 2007 Nov 21
PMID 18022241
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

A novel Ru(III) complex, mer-[RuCl(3)(CH(3)CN)(dpq)] (1), has been synthesized and characterized by X-ray diffraction, where dpq=dipyrido[3,2-d:2',3'-f]quinoxaline. Its chemical and biological properties have been intensively compared with those of mer-[RuCl(3)(DMSO)(dpq)] (DMSO=dimethyl sulfoxide) (2). It has been found that the stability in buffered solutions and the reduction potential for the Ru(III)/Ru(II) couple can be modulated by changing the small molecule bonded to the Ru(III) center. Interactions of 1 with DNA have been investigated by DNA melting experiments, DNA competitive binding with EB (ethidium bromide), plasmid DNA cleavage experiments and viscosity measurements. The interaction of 1 and 2 with BSA (bovine serum albumin) has also been studied using fluorescent quenching method. The experimental results show that 1 exerts higher affinity towards DNA and BSA than 2 does. The cytotoxicity of 1 has been evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method, and 2 shows slightly higher anticancer potency than 1 does against all the cell lines screened. Attempts are made to clarify the possible antitumor mechanisms of these two complexes by analyzing the experimental results presented.

Citing Articles

Mononuclear η-arene ruthenium(II) complexes with pyrazolyl-pyridazine ligands: synthesis, CT-DNA binding, reactivity towards glutathione, and cytotoxicity.

Kanyora A, Omondi R, Ongoma P, Omolo J, Welsh A, Prince S J Biol Inorg Chem. 2024; 29(2):251-264.

PMID: 38494554 DOI: 10.1007/s00775-024-02043-3.


The link between relative stability constant of DNA- and BSA-chromenopyrimidine complexes and cytotoxicity towards human breast cancer cells (MCF-7).

Zamisa S, Adeleke A, Devnarain N, Rhman M, Owira P, Omondi B RSC Adv. 2023; 13(32):21820-21837.

PMID: 37475760 PMC: 10354499. DOI: 10.1039/d3ra01741a.


pH-Sensitive Gold Nanorods for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Delivery and DNA-Binding Studies.

Zygouri E, Bekiari V, Malis G, Karamanos N, Koutsakis C, Psomas G Molecules. 2023; 28(9).

PMID: 37175189 PMC: 10179929. DOI: 10.3390/molecules28093780.


Iron(III) Complexes with Non-Steroidal Anti-Inflammatory Drugs: Structure, Antioxidant and Anticholinergic Activity, and Interaction with Biomolecules.

Dimiza F, Barmpa A, Chronakis A, Hatzidimitriou A, Sanakis Y, Papadopoulos A Int J Mol Sci. 2023; 24(7).

PMID: 37047364 PMC: 10094617. DOI: 10.3390/ijms24076391.


Investigating the Interaction of an Anticancer Nucleolipidic Ru(III) Complex with Human Serum Proteins: A Spectroscopic Study.

Riccardi C, Campanella A, Montesarchio D, Del Vecchio P, Oliva R, Paduano L Molecules. 2023; 28(6).

PMID: 36985771 PMC: 10055563. DOI: 10.3390/molecules28062800.